decisionhealth Newsletters, Part B News - 2005 Issue 9 (September)
Key ASP drug price changes for 4th quarter
Subscribe or sign in to view the full article.
Article Overview
This article reviews CMS’s fourth-quarter ASP update and summarizes how drug pricing changed for commonly billed physician office drugs under the Medicare Part B reimbursement framework. It is aimed at coders, billing staff, and reimbursement professionals who track quarterly payment updates, market movement, and selected high-volume drug price changes affecting office-based administration. The article also notes CMS’s monitoring process and provides a market-level view of pricing stability and shifts during 2005.
Why This Topic Matters
Quarterly ASP updates can affect reimbursement expectations, claims processing, and payment monitoring for physician practices and suppliers. Understanding the scope of the update helps readers assess whether the article is relevant to their Medicare Part B drug billing and pricing workflow.
Article Sections
-
Quarterly ASP update overview
Summarizes CMS’s fourth-quarter pricing update for physician-billed drugs and the general timing of the change. It also introduces the broader market context for the update.
-
CMS pricing and market observations
Describes general observations about pricing stability, utilization, market shifts, and CMS monitoring activities. It also touches on vendor pricing review and related payment oversight.
-
High-volume drugs with significant price increases
Presents a selected list of commonly billed drugs that experienced notable upward price movement in the fourth quarter. The section is organized as a comparison of quarterly pricing changes.
-
High-volume drugs with significant price decreases
Presents a selected list of commonly billed drugs that experienced notable downward price movement in the fourth quarter. The section is organized as a comparison of quarterly pricing changes.
What You Will Learn
- How CMS’s quarterly ASP update affects the broader drug pricing environment
- What types of market factors may influence drug price movement
- Which broad categories of high-volume physician-billed drugs experienced notable price shifts
- How CMS and vendors interact in the context of ASP pricing oversight
- What kinds of Part B drug pricing changes were highlighted for the quarter
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Physician practice managers
- Drug pricing and compliance analysts
- Medicare Part B suppliers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com